{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:05:46Z","timestamp":1793066746834,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41433-023-02462-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T15:49:03Z","timestamp":1679845743000},"page":"2877-2885","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical trials targeting the gut-microbiome to effect ocular health: a systematic review"],"prefix":"10.1038","volume":"37","author":[{"given":"Matthew W.","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C.","family":"Muste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-9560","authenticated-orcid":false,"given":"Blanche L.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8162","authenticated-orcid":false,"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"2462_CR1","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1080\/07853890.2021.1925150","volume":"53","author":"P Napolitano","year":"2021","unstructured":"Napolitano P, Filippelli M, Davinelli S, Bartollino S, dell\u2019Omo R, Costagliola C. Influence of gut microbiota on eye diseases: an overview. Ann Med. 2021;53:750\u201361. https:\/\/doi.org\/10.1080\/07853890.2021.1925150","journal-title":"Ann Med"},{"key":"2462_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.20180448","volume":"216","author":"J Durack","year":"2019","unstructured":"Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216:20\u201340. https:\/\/doi.org\/10.1084\/jem.20180448","journal-title":"J Exp Med"},{"key":"2462_CR3","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/odi.12472","volume":"22","author":"TA van der Meulen","year":"2016","unstructured":"van der Meulen TA, Harmsen H, Bootsma H, Spijkervet F, Kroese F, Vissink A. The microbiome-systemic diseases connection. Oral Dis. 2016;22:719\u201334. https:\/\/doi.org\/10.1111\/odi.12472","journal-title":"Oral Dis"},{"key":"2462_CR4","unstructured":"Gut microbiome in retina health: the crucial role of the gut-retina axis. Front Microbiol. Accessed 7 Mar 2022. https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.726792\/full"},{"key":"2462_CR5","doi-asserted-by":"crossref","unstructured":"Xue W, Li JJ, Zou Y, Zou B, Wei L. Microbiota and ocular diseases. Front Cell Infect Microbiol. 2021;11. Accessed 7 Mar 2022. https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2021.759333","DOI":"10.3389\/fcimb.2021.759333"},{"key":"2462_CR6","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bpg.2017.10.008","volume":"31","author":"D Radjabzadeh","year":"2017","unstructured":"Radjabzadeh D, Uitterlinden AG, Kraaij R. Microbiome measurement: possibilities and pitfalls. Best Pr Res Clin Gastroenterol. 2017;31:619\u201323. https:\/\/doi.org\/10.1016\/j.bpg.2017.10.008","journal-title":"Best Pr Res Clin Gastroenterol"},{"key":"2462_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cgh.2018.09.017","volume":"17","author":"C Allaband","year":"2019","unstructured":"Allaband C, McDonald D, V\u00e1zquez-Baeza Y, et al. Microbiome 101: studying, analyzing, and interpreting gut microbiome data for clinicians. Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc. 2019;17:218\u201330. https:\/\/doi.org\/10.1016\/j.cgh.2018.09.017","journal-title":"Clin Gastroenterol Hepatol Clin Pr J Am Gastroenterol Assoc"},{"key":"2462_CR8","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1167\/iovs.16-19733","volume":"57","author":"YK Nakamura","year":"2016","unstructured":"Nakamura YK, Metea C, Karstens L, et al. Gut microbial alterations associated with protection from autoimmune uveitis. Invest Ophthalmol Vis Sci. 2016;57:3747\u201358. https:\/\/doi.org\/10.1167\/iovs.16-19733","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2462_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.immuni.2015.07.014","volume":"43","author":"R Horai","year":"2015","unstructured":"Horai R, Z\u00e1rate-Blad\u00e9s CR, Dillenburg-Pilla P, et al. Microbiota-dependent activation of an autoreactive T cell receptor provokes autoimmunity in an immunologically privileged site. Immunity. 2015;43:343\u201353. https:\/\/doi.org\/10.1016\/j.immuni.2015.07.014","journal-title":"Immunity"},{"key":"2462_CR10","doi-asserted-by":"publisher","first-page":"E4472","DOI":"10.1073\/pnas.1702302114","volume":"114","author":"S Rowan","year":"2017","unstructured":"Rowan S, Jiang S, Korem T, et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci USA. 2017;114:E4472\u201381. https:\/\/doi.org\/10.1073\/pnas.1702302114","journal-title":"Proc Natl Acad Sci USA"},{"key":"2462_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05681-9","volume":"9","author":"H Chen","year":"2018","unstructured":"Chen H, Cho KS, Vu THK, et al. Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma. Nat Commun. 2018;9:3209. https:\/\/doi.org\/10.1038\/s41467-018-05681-9","journal-title":"Nat Commun"},{"key":"2462_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCRESAHA.119.315743","volume":"125","author":"Y Duan","year":"2019","unstructured":"Duan Y, Prasad R, Feng D, et al. Bone marrow-derived cells restore functional integrity of the gut epithelial and vascular barriers in a model of diabetes and ACE2 deficiency. Circ Res. 2019;125:969\u201388. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315743","journal-title":"Circ Res"},{"key":"2462_CR13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2337\/db18-0158","volume":"67","author":"E Beli","year":"2018","unstructured":"Beli E, Yan Y, Moldovan L, et al. Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db\/db mice. Diabetes. 2018;67:1867\u201379. https:\/\/doi.org\/10.2337\/db18-0158","journal-title":"Diabetes"},{"key":"2462_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","volume":"14","author":"A Verma","year":"2019","unstructured":"Verma A, Xu K, Du T, et al. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol Ther Methods Clin Dev. 2019;14:161\u201370. https:\/\/doi.org\/10.1016\/j.omtm.2019.06.007","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2462_CR15","unstructured":"Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009)\u2014Centre for Evidence-Based Medicine (CEBM), University of Oxford. Accessed 16 Jun 2022. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009"},{"key":"2462_CR16","unstructured":"Costagliola C. Effect of probiotics on the occurrence of blepharitis in adults and children. clinicaltrials.gov; 2021. Accessed 16 Mar 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04742855"},{"key":"2462_CR17","unstructured":"Lebeer S. Study of the Probiotic Potential of a Lacticaseibacillus Strain in the Upper Airways in Patients With Allergic Rhinoconjunctivitis After Administration in a Chewable. clinicaltrials.gov; 2021. Accessed 16 Mar 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04898686"},{"key":"2462_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82538-0","volume":"11","author":"T Das","year":"2021","unstructured":"Das T, Jayasudha R, Chakravarthy S, et al. Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy. Sci Rep. 2021;11:2738. https:\/\/doi.org\/10.1038\/s41598-021-82538-0","journal-title":"Sci Rep"},{"key":"2462_CR19","doi-asserted-by":"publisher","first-page":"667632","DOI":"10.3389\/fmicb.2021.667632","volume":"12","author":"P Ye","year":"2021","unstructured":"Ye P, Zhang X, Xu Y, Xu J, Song X, Yao K. Alterations of the gut microbiome and metabolome in patients with proliferative diabetic retinopathy. Front Microbiol. 2021;12:667632. https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2021.667632 Accessed 8 Mar 2022.","journal-title":"Front Microbiol"},{"key":"2462_CR20","doi-asserted-by":"publisher","first-page":"646348","DOI":"10.3389\/fcimb.2021.646348","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang Z, Ma H, et al. Dysbiosis and implication of the gut microbiota in diabetic retinopathy. Front Cell Infect Microbiol. 2021;11:646348. https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2021.646348 Accessed March 8, 2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2462_CR21","doi-asserted-by":"publisher","first-page":"e0243077","DOI":"10.1371\/journal.pone.0243077","volume":"15","author":"R Jayasudha","year":"2020","unstructured":"Jayasudha R, Das T, Kalyana Chakravarthy S, et al. Gut mycobiomes are altered in people with type 2 diabetes mellitus and diabetic retinopathy. PloS One. 2020;15:e0243077. https:\/\/doi.org\/10.1371\/journal.pone.0243077","journal-title":"PloS One"},{"key":"2462_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/microorganisms8091347","volume":"8","author":"H Singh","year":"2020","unstructured":"Singh H, Miyamoto S, Darshi M, et al. Gut microbial changes in diabetic db\/db mice and recovery of microbial diversity upon pirfenidone treatment. Microorganisms. 2020;8:1347. https:\/\/doi.org\/10.3390\/microorganisms8091347","journal-title":"Microorganisms"},{"key":"2462_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep40826","volume":"7","author":"MS Zinkernagel","year":"2017","unstructured":"Zinkernagel MS, Zysset-Burri DC, Keller I, et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci Rep. 2017;7:40826. https:\/\/doi.org\/10.1038\/srep40826","journal-title":"Sci Rep"},{"key":"2462_CR24","doi-asserted-by":"publisher","first-page":"e1854","DOI":"10.7717\/peerj.1854","volume":"4","author":"MN Conley","year":"2016","unstructured":"Conley MN, Wong CP, Duyck KM, Hord N, Ho E, Sharpton TJ. Aging and serum MCP-1 are associated with gut microbiome composition in a murine model. PeerJ. 2016;4:e1854. https:\/\/doi.org\/10.7717\/peerj.1854","journal-title":"PeerJ"},{"key":"2462_CR25","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/ueg2.12136","volume":"9","author":"ZE McPherson","year":"2021","unstructured":"McPherson ZE, S\u00f8rensen HT, Horv\u00e1th-Puh\u00f3 E, et al. Irritable bowel syndrome and risk of glaucoma: an analysis of two independent population-based cohort studies. U Eur Gastroenterol J. 2021;9:1057\u201365. https:\/\/doi.org\/10.1002\/ueg2.12136","journal-title":"U Eur Gastroenterol J"},{"key":"2462_CR26","doi-asserted-by":"publisher","first-page":"107921","DOI":"10.1016\/j.exer.2020.107921","volume":"191","author":"H Gong","year":"2020","unstructured":"Gong H, Zhang S, Li Q, et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma. Exp Eye Res. 2020;191:107921. https:\/\/doi.org\/10.1016\/j.exer.2020.107921","journal-title":"Exp Eye Res"},{"key":"2462_CR27","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1097\/WNO.0000000000001330","volume":"42","author":"E Berkowitz","year":"2022","unstructured":"Berkowitz E, Kopelman Y, Kadosh D, et al. \u201cMore guts than brains?\u201d\u2014The role of gut microbiota in idiopathic intracranial hypertension. J Neuroophthalmol. 2022;42:e70. https:\/\/doi.org\/10.1097\/WNO.0000000000001330","journal-title":"J Neuroophthalmol"},{"key":"2462_CR28","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1136\/gutjnl-2020-322670","volume":"70","author":"LA Bolte","year":"2021","unstructured":"Bolte LA, Vich Vila A, Imhann F, et al. Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome. Gut. 2021;70:1287\u201398. https:\/\/doi.org\/10.1136\/gutjnl-2020-322670","journal-title":"Gut"},{"key":"2462_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/microorganisms7080271","volume":"7","author":"S Lobionda","year":"2019","unstructured":"Lobionda S, Sittipo P, Kwon HY, Lee YK. The role of gut microbiota in intestinal inflammation with respect to diet and extrinsic stressors. Microorganisms. 2019;7:271. https:\/\/doi.org\/10.3390\/microorganisms7080271","journal-title":"Microorganisms"},{"key":"2462_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/nu3060637","volume":"3","author":"A Hakansson","year":"2011","unstructured":"Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011;3:637\u201382. https:\/\/doi.org\/10.3390\/nu3060637","journal-title":"Nutrients"},{"key":"2462_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12088-018-0746-9","volume":"58","author":"S Kalyana Chakravarthy","year":"2018","unstructured":"Kalyana Chakravarthy S, Jayasudha R, Sai Prashanthi G, et al. Dysbiosis in the gut bacterial microbiome of patients with uveitis, an inflammatory disease of the eye. Indian J Microbiol. 2018;58:457\u201369. https:\/\/doi.org\/10.1007\/s12088-018-0746-9","journal-title":"Indian J Microbiol"},{"key":"2462_CR32","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1167\/iovs.17-22677","volume":"59","author":"X Huang","year":"2018","unstructured":"Huang X, Ye Z, Cao Q, et al. Gut microbiota composition and fecal metabolic phenotype in patients with acute anterior uveitis. Investig Ophthalmol Vis Sci. 2018;59:1523\u201331. https:\/\/doi.org\/10.1167\/iovs.17-22677","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2462_CR33","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1167\/iovs.18-26426","volume":"60","author":"R Jayasudha","year":"2019","unstructured":"Jayasudha R, Kalyana Chakravarthy S, Sai Prashanthi G, Sharma S, Tyagi M, Shivaji S. Implicating dysbiosis of the gut fungal microbiome in uveitis, an inflammatory disease of the eye. Investig Ophthalmol Vis Sci. 2019;60:1384\u201393. https:\/\/doi.org\/10.1167\/iovs.18-26426","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2462_CR34","doi-asserted-by":"publisher","first-page":"e0199640","DOI":"10.1371\/journal.pone.0199640","volume":"13","author":"SK Chakravarthy","year":"2018","unstructured":"Chakravarthy SK, Jayasudha R, Ranjith K, et al. Alterations in the gut bacterial microbiome in fungal Keratitis patients. PLOS One. 2018;13:e0199640. https:\/\/doi.org\/10.1371\/journal.pone.0199640","journal-title":"PLOS One"},{"key":"2462_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12038-018-9798-6","volume":"43","author":"R Jayasudha","year":"2018","unstructured":"Jayasudha R, Chakravarthy SK, Prashanthi GS, et al. Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye. J Biosci. 2018;43:835\u201356.","journal-title":"J Biosci"},{"key":"2462_CR36","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1099\/jmm.0.013227-0","volume":"59","author":"RJ Kothavade","year":"2010","unstructured":"Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59:873\u201380. https:\/\/doi.org\/10.1099\/jmm.0.013227-0","journal-title":"J Med Microbiol"},{"key":"2462_CR37","doi-asserted-by":"publisher","first-page":"e0241691","DOI":"10.1371\/journal.pone.0241691","volume":"15","author":"D Tecer","year":"2020","unstructured":"Tecer D, Gogus F, Kalkanci A, et al. Succinivibrionaceae is dominant family in fecal microbiota of Beh\u00e7et\u2019s Syndrome patients with uveitis. PloS One. 2020;15:e0241691. https:\/\/doi.org\/10.1371\/journal.pone.0241691","journal-title":"PloS One"},{"key":"2462_CR38","first-page":"60","volume":"38127","author":"NS Yasar Bilge","year":"2020","unstructured":"Yasar Bilge NS, P\u00e9rez Brocal V, Kasifoglu T, et al. Intestinal microbiota composition of patients with Beh\u00e7et\u2019s disease: differences between eye, mucocutaneous and vascular involvement. The Rheuma-BIOTA study. Clin Exp Rheumatol. 2020;38(Suppl 127):60\u201368.","journal-title":"Clin Exp Rheumatol"},{"key":"2462_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52082-z","volume":"9","author":"C Roncal","year":"2019","unstructured":"Roncal C, Mart\u00ednez-Aguilar E, Orbe J, et al. Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Sci Rep. 2019;9:15580. https:\/\/doi.org\/10.1038\/s41598-019-52082-z","journal-title":"Sci Rep"},{"key":"2462_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111\u201324. https:\/\/doi.org\/10.1016\/j.cell.2016.02.011","journal-title":"Cell"},{"key":"2462_CR41","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts AB, Gu X, Buffa JA, et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018;24:1407\u201317. https:\/\/doi.org\/10.1038\/s41591-018-0128-1","journal-title":"Nat Med"},{"key":"2462_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51698-5","volume":"9","author":"DC Zysset-Burri","year":"2019","unstructured":"Zysset-Burri DC, Keller I, Berger LE, et al. Retinal artery occlusion is associated with compositional and functional shifts in the gut microbiome and altered trimethylamine-N-oxide levels. Sci Rep. 2019;9:15303. https:\/\/doi.org\/10.1038\/s41598-019-51698-5","journal-title":"Sci Rep"},{"key":"2462_CR43","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1039\/c9fo00333a","volume":"10","author":"LE Griffin","year":"2019","unstructured":"Griffin LE, Djuric Z, Angiletta CJ, et al. A Mediterranean diet does not alter plasma trimethylamine N-oxide concentrations in healthy adults at risk for colon cancer. Food Funct. 2019;10:2138\u201347. https:\/\/doi.org\/10.1039\/c9fo00333a","journal-title":"Food Funct"},{"key":"2462_CR44","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2021.06.022","volume":"233","author":"A Watane","year":"2022","unstructured":"Watane A, Cavuoto KM, Rojas M, et al. Fecal microbial transplant in individuals with immune-mediated dry eye. Am J Ophthalmol. 2022;233:90\u2013100. https:\/\/doi.org\/10.1016\/j.ajo.2021.06.022","journal-title":"Am J Ophthalmol"},{"key":"2462_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.18240\/ijo.2022.01.06","volume":"15","author":"M Filippelli","year":"2022","unstructured":"Filippelli M, dell\u2019Omo R, Amoruso A, et al. Effectiveness of oral probiotics supplementation in the treatment of adult small chalazion. Int J Ophthalmol. 2022;15:40\u201344. https:\/\/doi.org\/10.18240\/ijo.2022.01.06","journal-title":"Int J Ophthalmol"},{"key":"2462_CR46","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00431-020-03880-5","volume":"180","author":"M Filippelli","year":"2021","unstructured":"Filippelli M, dell\u2019Omo R, Amoruso A, et al. Intestinal microbiome: a new target for chalaziosis treatment in children? Eur J Pediatr. 2021;180:1293\u20138. https:\/\/doi.org\/10.1007\/s00431-020-03880-5","journal-title":"Eur J Pediatr"},{"key":"2462_CR47","doi-asserted-by":"publisher","first-page":"e931321","DOI":"10.12659\/AJCR.931321","volume":"22","author":"P Napolitano","year":"2021","unstructured":"Napolitano P, Filippelli M, D\u2019andrea L, Carosielli M, dell\u2019Omo R, Costagliola C. Probiotic supplementation improved acute anterior uveitis of 3-year duration: a case report. Am J Case Rep. 2021;22:e931321. https:\/\/doi.org\/10.12659\/AJCR.931321","journal-title":"Am J Case Rep"},{"key":"2462_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49452-y","volume":"9","author":"LJ Wilkins","year":"2019","unstructured":"Wilkins LJ, Monga M, Miller AW. Defining dysbiosis for a cluster of chronic diseases. Sci Rep. 2019;9:12918. https:\/\/doi.org\/10.1038\/s41598-019-49452-y","journal-title":"Sci Rep"},{"key":"2462_CR49","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.1016\/j.cell.2021.06.019","volume":"184","author":"HC Wastyk","year":"2021","unstructured":"Wastyk HC, Fragiadakis GK, Perelman D, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184:4137.e14. https:\/\/doi.org\/10.1016\/j.cell.2021.06.019","journal-title":"Cell"},{"key":"2462_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41424-018-0030-7","volume":"9","author":"SSC Rao","year":"2018","unstructured":"Rao SSC, Rehman A, Yu S, Andino NMde. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. Clin Transl Gastroenterol. 2018;9:162. https:\/\/doi.org\/10.1038\/s41424-018-0030-7","journal-title":"Clin Transl Gastroenterol"},{"key":"2462_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psyneuen.2018.10.010","volume":"100","author":"L Rudzki","year":"2019","unstructured":"Rudzki L, Ostrowska L, Pawlak D, et al. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology. 2019;100:213\u201322. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.10.010","journal-title":"Psychoneuroendocrinology"},{"key":"2462_CR52","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1099\/jmm.0.056663-0","volume":"62","author":"JP Burton","year":"2013","unstructured":"Burton JP, Drummond BK, Chilcott CN, et al. Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial. J Med Microbiol. 2013;62:875\u201384. https:\/\/doi.org\/10.1099\/jmm.0.056663-0","journal-title":"J Med Microbiol"},{"key":"2462_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jdi.12863","volume":"10","author":"A Kijmanawat","year":"2019","unstructured":"Kijmanawat A, Panburana P, Reutrakul S, Tangshewinsirikul C. Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: a double-blind randomized controlled trial. J Diabetes Investig. 2019;10:163\u201370. https:\/\/doi.org\/10.1111\/jdi.12863","journal-title":"J Diabetes Investig"},{"key":"2462_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent clostridium difficile. N Engl J Med. 2013;368:407\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1205037","journal-title":"N Engl J Med"},{"key":"2462_CR55","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1177\/2050640619854587","volume":"7","author":"T Rokkas","year":"2019","unstructured":"Rokkas T, Gisbert JP, Gasbarrini A, et al. A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. U Eur Gastroenterol J. 2019;7:1051\u201363. https:\/\/doi.org\/10.1177\/2050640619854587","journal-title":"U Eur Gastroenterol J"},{"key":"2462_CR56","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.gastro.2020.07.013","volume":"160","author":"T Holvoet","year":"2021","unstructured":"Holvoet T, Joossens M, V\u00e1zquez-Castellanos JF, et al. Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial. Gastroenterology. 2021;160:145.e8. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.013","journal-title":"Gastroenterology"},{"key":"2462_CR57","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s42000-020-00265-z","volume":"20","author":"JR Allegretti","year":"2021","unstructured":"Allegretti JR, Kassam Z, Hurtado J, et al. Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity. Hormones. 2021;20:209\u201311. https:\/\/doi.org\/10.1007\/s42000-020-00265-z","journal-title":"Hormones"},{"key":"2462_CR58","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/d41573-019-00122-8","volume":"18","author":"M Cully","year":"2019","unstructured":"Cully M. Microbiome therapeutics go small molecule. Nat Rev Drug Discov. 2019;18:569\u201372. https:\/\/doi.org\/10.1038\/d41573-019-00122-8","journal-title":"Nat Rev Drug Discov"},{"key":"2462_CR59","doi-asserted-by":"publisher","unstructured":"Moubayed NM, Bhat RS, Al Farraj D, et al. Screening and identification of gut anaerobes (Bacteroidetes) from human diabetic stool samples with and without retinopathy in comparison to control subjects. Microb Pathog. 2019;129:88\u201392. https:\/\/doi.org\/10.1016\/j.micpath.2019.01.025","DOI":"10.1016\/j.micpath.2019.01.025"},{"key":"2462_CR60","doi-asserted-by":"publisher","unstructured":"Skondra D, Rodriguez SH, Sharma A, et al. The early gut microbiome could protect against severe retinopathy of prematurity. J AAPOS. 2020;24:236\u20138. https:\/\/doi.org\/10.1016\/j.jaapos.2020.03.010","DOI":"10.1016\/j.jaapos.2020.03.010"},{"key":"2462_CR61","doi-asserted-by":"publisher","unstructured":"Khan R, Sharma A, Ravikumar R, et al. Association Between Gut Microbial Abundance and Sight-Threatening Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2021;62:19. https:\/\/doi.org\/10.1167\/iovs.62.7.19","DOI":"10.1167\/iovs.62.7.19"},{"key":"2462_CR62","doi-asserted-by":"publisher","unstructured":"Moon J, Choi SH, Yoon CH, et al. Gut dysbiosis is prevailing in Sj\u00f6gren\u2019s syndrome and is related to dry eye severity. PLoS One. 2020;15:e0229029. https:\/\/doi.org\/10.1371\/journal.pone.0229029","DOI":"10.1371\/journal.pone.0229029"},{"key":"2462_CR63","doi-asserted-by":"publisher","unstructured":"Mendez R, Watane A, Farhangi M, et al. Gut microbial dysbiosis in individuals with Sj\u00f6gren\u2019s syndrome. Microbial Cell Factories. 2020;19:90. https:\/\/doi.org\/10.1186\/s12934-020-01348-7","DOI":"10.1186\/s12934-020-01348-7"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02462-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02462-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02462-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T07:06:34Z","timestamp":1695366394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02462-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":63,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02462-7","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RPS reports personal fees from Genentech\/Roche, personal fees from Alcon\/Novartis, grants from Apellis and Graybug, personal fees from Zeiss, personal fees from Bausch + Lomb, personal fees from Regeneron Pharmaceuticals, Inc. All other authors report no disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}